Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peixuan Guo
University of Louisville, Department: Microbiology/immun/virology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Guangzhou Biomotor and RNA Nanotech Development Co. Ltd.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Per Dr. Peixuan Guo’s annual financial disclosure dated 3/16/15, he serves on the SAB, consults, is an equity interest holder and receives license revenue from Guangzhou Biomotor and RNA Nanotech Development Co. Ltd. Per Dr. Guo, he owns (b)(4) equity in this for profit, non-publicly traded company. This start-up company licensed Dr. Guo’s patent on the Phi 29 motor nanopore. The mission of this start-up company is to commercialize the RNA nanotechnology and the connector nanopore technology developed by Dr. Guo. Per Dr. Guo, the company has since been looking for investors to take over their business, however this has not been finalized.
Fruit exosome-like particles for therapeutic delivery of extracellular miRNAs
The concept that extracellular RNA (exRNA) may alter target cell phenotypes by way of intercellular signaling is becoming universally accepted in science. Whether exRNA can be used as a therapeutic agent is not known. The overall goal of this study is to develop grape lipid derived nano vectors for the delivery of exRNAs as therapeutic agents to target tumor cells as well as inflammatory cells in animal tumor models. Additionally we will assess the therapeutic potential of exRNA used in a clinical setting.
Filed on May 25, 2015.
Tell us what you know about Peixuan Guo's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Peixuan Guo filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peixuan Guo | Ohio State University | Conflict of Interest | ExonanoRNA, LLC | $250,000 - $299,999 |
| Peixuan Guo | University of Louisville | Conflict of Interest | Guangzhou Biomotor and RNA Nanotech Development Co. Ltd. | $40,000 - $59,999 |
| Peixuan Guo | Ohio State University | Conflict of Interest | P & Z Biological Technology, LLC | $20,000 - $39,999 |
| Peixuan Guo | University of Louisville | Conflict of Interest | Nanobio Delivery Pharmaceutical | $10,000 - $19,999 |
| Peixuan Guo | Ohio State University | Conflict of Interest | P & Z Biological Technology, LLC | $0 - $4,999 |
| Peixuan Guo | University of Kentucky | Conflict of Interest | Biomotor and Nucleic Acid Nanotechnology Development Corporation, Ltd | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.